A new research report from U.S.-based Transparency Market Research examines the global antibacterial drugs market and arrives at studied conclusions about the market’s expected trajectory during the forecast period 2013-2019. The report states that the global market for antibacterial drugs was worth US$43.55 billion in 2012. Helped by factors such as the growing prevalence of bacterial diseases around the world and growth in geriatric population with weakened immune systems due to age, the market is expected to rise at a 0.3% CAGR from 2013 to 2019, to eventually reach a total value of US$45.09 billion.The report, titled ‘Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019’, draws on extensive primary and secondary research to formulate conclusions, employing trusted analytical tools such as Porter’s five forces analysis, market attractiveness analysis, and SWOT analysis.
Browse the full Antibacterial Drugs Market Report at http://www.transparencymarketresearch.com/antibacterial-drugs-market.html
Porter’s five forces analysis reveals the tussle between the established players and new entrants, threat to branded products from substitutes, and the relative power of buyers and suppliers. Use of market attractiveness analysis helps develop the crucial part of the report: recommendations for market players regarding the feasibility of investment in the market in the forecast period. SWOT analysis helps expand upon the competitive landscape of the market, to provide a comparative overview of the major players operating in the global antibacterial drugs market.“Despite the strong factors working in its favor, the global antibacterial drugs market is restrained by a number of equally influential issues. This is the reason why the CAGR of the market is expected to remain negligible in the forecast period,” states a TMR analyst.
Browse the full Press Release :...